Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)

v3.24.1
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Summary Of Significant Accounting Policies [Line Items]        
Operating lease right-of-use assets   $ 22,815,000 $ 26,443,000  
Operating lease liabilities current   6,420,000 4,585,000  
Total lease liabilities, non-current   23,154,000 29,574,000  
Restricted cash   872,000 872,000 $ 872,000
Impairment of long-lived assets   0 $ 0 $ 0
Blackstone Life Sciences        
Summary Of Significant Accounting Policies [Line Items]        
Upfront payment received $ 140,000,000 $ 140,000,000    
2015 License Member | Blackstone Life Sciences | Royalty Member        
Summary Of Significant Accounting Policies [Line Items]        
Revenue interest percentage 4.00% 4.00%    
Upfront payment received $ 140,000,000      
Accounting Standards Update 2016-02        
Summary Of Significant Accounting Policies [Line Items]        
Change in accounting principle, accounting standards update, adopted [true false]   true    
Change in accounting principle, accounting standards update, adoption date   Jul. 01, 2021    
Minimum        
Summary Of Significant Accounting Policies [Line Items]        
Property and equipment useful lives   3 years    
Maximum        
Summary Of Significant Accounting Policies [Line Items]        
Property and equipment useful lives   5 years    
Maximum | Blackstone Life Sciences        
Summary Of Significant Accounting Policies [Line Items]        
Milestone payment receivable $ 250,000,000 $ 250,000,000